The study aimed to evaluate the presence of pili in non-invasive pediatric pneumococcal isolates and to elucidate possible links with genetic lineages, serotypes, and antimicrobial resistance. We examined 147 Streptococcus pneumoniae isolates from children with respiratory tract infections and acute otitis media. Serotyping was performed by latex agglutination and capsule swelling reaction. Serogroup 6 was subjected to PCR-serotyping. Minimum inhibitory concentrations were determined according to EUCAST breakpoints. PCRs for rlrA and pitB genes were performed to detect a presence of type 1 and type 2 pili. MLST was conducted to define the clonal structure of the piliated strains. Almost all children (96.5%) were vaccinated with the pneumococcal conjugate vaccine PCV10. We detected 76.8% non-PCV10 – serotypes (NVTs) and 14.3% PCV10 serotypes. The predominant serotypes were NVTs: 19A (14.3%), 6C (12.2%), 3 (9.5%), 15A (7.5%) and 6A (6.8%). PI-1 was detected among 10.9% non-PCV10 serotypes 6A, 6C, and 19A and 6.1% PCV10 serotypes 19F and 23F. Type 2 pili were not found in the studied population. High levels of antimicrobial nonsusceptibility to erythromycin (58.5%), oral penicillin (55.8%), clindamycin (46.9%), trimethoprim-sulfamethoxazole (45.6%), tetracycline (39.5%) and ceftriaxone (16.3%) were revealed. The multidrug-resistant strains (MDR) were 55.1%. MLST represented 18 STs and three CCs among the piliated pneumococci: CC386, CC320, and CC81. More than half of the piliated strains (56.0%) belonged to successfully circulating international clones. PI-1 was associated mainly with MDR 6A, 6C, 19A, 19F, and 23F isolates from the widespread CC386, CC320, and CC81.
Maraqa FN. Pneumococcal infections. Pediatr Rev 2014; 35(7): 299–310.
Brooks LRK, Mias GI. Streptococcus pneumoniae's virulence and host immunity: aging, diagnostics, and prevention. Front Immunol 2018; 22(9): 1366.
Subramanian K, Henriques-Normark B, Normark S. Emerging concepts in the pathogenesis of the Streptococcus pneumoniae: From nasopharyngeal colonizer to intracellular pathogen. Cell Microbiol 2019; 21(11): e13077.
Danne C, Dramsi S. Pili of gram-positive bacteria: roles in host colonization. Res Microbiol 2012; 163(9–10): 645–58.
Henriques-Normark B, Tuomanen E. The pneumococcus: epidemiology, microbiology, and pathogenesis. Cold Spring Harb Perspect Med 2013 PMID: 23818515.
Blumental S, Granger-Farbos A, Moïsi J, Soullie B, Leroy P, Njanpop-Lafourcade B, et al.. Virulence factors of Streptococcus pneumoniae. Comparison between African and French invasive isolates and implication for future vaccines. PLoS One 2015; 27; 10(7): e0133885. Available from: https://doi.org/10.1371/journal.pone.0133885.
Barocchi MA, Ries J, Zogaj X, Hemsley C, Albiger B, Kanth A, et al.. A pneumococcal pilus influences virulence and host inflammatory responses. Proc Natl Acad Sci USA 2006; 103: 2857–62.
Bagnoli F, Moschioni M, Donati C, Dimitrovska V, Ferlenghi I, Facciotti C, et al.. A second pilus type in Streptococcus pneumoniae is prevalent in emerging serotypes and mediates adhesion to host cells. J Bacteriol 2008; 190: 5480–92.
Aguiar S, Serrano I, Pinto F, Melo-Christino J, Ramirez M. The presence of the pilus locus is a clonal property among pneumococcal invasive isolates. BMC Microbiol 2008; 28(8): 41.
Nelson AL, Dahlberg S, Falker S, Rounioja S, et al.. RrgA is a pilus-associated adhesin in Streptococcus pneumoniae. Mol Microbiol 2007; 66(2): 329–340.
Figueira M, Moschioni M, De Angelis G, Barocchi M, Sabharwal V, Masignani V, et al.. Variation of pneumococcal Pilus-1 expression results in vaccine escape during Experimental Otitis Media [EOM]. PLoS One 2014; 9(1): e83798. Available from: https://doi.org/10.1371/journal.pone.0083798.
Turner P, Melchiorre S, Moschioni M, Barocchi M, Turner C, Watthanaworawit W, et al.. Assessment of Streptococcus pneumoniae pilus islet-1 prevalence in carried and transmitted isolates from mother-infant pairs on the Thailand Burma border. Clin Microbiol Infect 2012; 18(10): 970–5.
Kulohoma BW, Gray K, Kamng’ona A, Cornick J, Bentley S, Heyderman R, et al.. Piliation of invasive Streptococcus pneumoniae isolates in the era before pneumococcal conjugate vaccine introduction in Malawi. Clin Vaccin Immunol 2013; 20: 1729–35.
Ganaie F, Maruhn K, Li C, Porambo R, Elverdal P, Abeygunwardana C, et al.. Structural, genetic, and serological elucidation of Streptococcus pneumoniae serogroup 24 serotypes: discovery of a new serotype, 24C, with a variable capsule structure. J Clin Microbiol 2021; 59(7): e0054021. Available from: https://doi.org/10.1128/JCM.00540-21.
Moschioni M, De Angelis G, Melchiorre S, Masignoni V, Leibovitz E, Barocchi M, et al.. Prevalence of pilus-encoding islets among acute otitis media Streptococcus pneumoniae isolates from Israel. Clin Microbiol Infect 2010; 16: 1501–4.
Regev-Yochay G, Hanage WP, Trzcinski K, Rifas-Shiman S, Lee G, Bessolo A, et al.. Re-emergence of the type 1 pilus among Streptococcus pneumoniae isolates in Massachusetts, USA. Vaccine 2010; 28(30): 4842–4846.
Hjalmarsdottir MA, Petursdottir B, Erlendsdottir H, Haraldsson G, Kristinsson K. Prevalence of pilus genes in pneumococci isolated from healthy preschool children in Iceland: association with vaccine serotypes and antibiotic resistance. J Antimicrob Chemother 2015; 70(8): 2203–8.
Greve T, Møller JK. Accuracy of using the lytA gene to distinguish Streptococcus pneumoniae from related species. J Med Microbiol 2012; 61: 478–482.
Jin P, Xiao M, Kong F, Oftadeh S, Zhou F, Liu C, et al.. Simple, accurate, serotype-specific PCR assay to differentiate Streptococcus pneumoniae serotypes 6A, 6B, and 6C. J Clin Microbiol 2009; 47(8): 2470–4. Available from: https://doi.org/10.1128/JCM.00484-09.
European committee on antimicrobial susceptibility testing breakpoint tables for interpretation of MICs and zone diameters version 10.0, valid from 2021-01-01.
Gladstone R, Lo S, Lees J, Croucher N, van Tonder A, Corander J, et al.. International genomic definition of pneumococcal lineages, to contextualise disease, antibiotic resistance and vaccine impact. EBioMedicine 2019; 43: 338–46. Available from: https://doi.org/10.1016/j.ebiom.2019.04.021.
Kriger O, Yochay G. The effect of pneumococcal conjugate vaccine on pneumococcal carriage and invasive disease. Harefuah 2019; 158(5): 316–20.
McElligott M, Vickers I, Cafferkey M, Cunney R, Humphreys H. Non-invasive pneumococcal serotypes and antimicrobial susceptibilities in a paediatric hospital in the era of conjugate vaccines. Vaccine 2014; 32(28): 3495–500.
Setchanova L, Kostyanev T, Alexandrova A, Mitov I, Nashev D, Kantardjiev T. Microbiological characterization of Streptococcus pneumoniae and non-typeable Haemophilus influenzae isolates as primary causes of acute otitis media in Bulgarian children before the introduction of conjugate vaccines. Ann Clin Microbiol Antimicrobials 2013; 12: 6. Available from: https://doi.org/10.1186/1476-0711-12-6.
Alexandrova A, Setchanova L, Pencheva D, Mitov I. Phenotypic and genotypic characterization of serogroup 6 Streptococcus pneumoniae isolates collected during 10-valent pneumococcal conjugate vaccine era in Bulgaria. Acta Microbiol Immunol Hung 2020; 67(2): 91–9.
Kovács E, Sahin-Tóth J, Tóthpál A, Kristóf K, van der Linden M, Tirczka T, et al.. Vaccine-driven serotype-rearrangement is seen with latency in clinical isolates: comparison of carried and clinical pneumococcal isolates from the same time period in Hungary. Vaccine 2019 Jan 3; 37(1): 99–108. Available from: https://doi.org/10.1016/j.vaccine.2018.11.026.
Yamba Yamba L, Uddén F, Fuursted K, Ahl J, Slotved HC, Riesbeck K. Extensive/multidrug resistant pneumococci detected in clinical respiratory tract samples in Southern Sweden are closely related to international multidrug-resistant lineages. Front Cell Infect Microbiol 2022 Mar 22; 12: 824449. https://doi.org/10.3389/fcimb.2022.824449.
Azarian T, Mitchell PK, Georgieva M, Thompson C, Ghoulia A, Pollard A, et al.. Global emergence and population dynamics of divergent serotype 3 CC180 pneumococci. Plos Pathog 2018; 14:e1007438.
Song JH, Dagan R, Klugman KP, Fritzell B. The relationship between pneumococcal serotypes and antibiotic resistance. Vaccine 2012; 30(17): 2728–37.
Kawaguchiya M, Urushibara N, Aung MS, Ito M, Takahashi A, Habadera S, et al. High prevalence of antimicrobial resistance in non-vaccine serotypes of non-invasive/colonization isolates of Streptococcus pneumoniae: a cross-sectional study eight years after the licensure of conjugate vaccine in Japan. J Infect Public Health 2020; 13(8): 1094–100.
Cherazard R, Epstein M, Doan TL, Salim T, Bharti S, Smith M. Antimicrobial resistant Streptococcus pneumoniae: prevalence, mechanisms, and clinical implications. Am J Ther 2017; 24(3): e361-9. Available from: https://doi.org/10.1097/MJT.0000000000000551.
Regev-Yochay G, Jaber H, Hamdan A, Daana M, Nammouz H, Thalji A, et al.. Vaccine escape of piliated Streptococcus pneumoniae strains. Vaccine 2016 May 27; 34(25): 2787–92.
Dzaraly ND, Muthanna A, Mohd Desa MN, Taib NM, Masri SN, Rahman N, et al.. Pilus islets and the clonal spread of piliated Streptococcus pneumoniae: a review. Int J Med Microbiol 2020 Oct; 310(7): 151449.
Del Grosso M, Camilli R, D’Ambrosio F, Petrucci G, Melchiorre S, Moschioni M, et al.. Increase of pneumococcal serotype 19A in Italy is due to expansion of the piliated clone ST416/CC199. J Med Microbiol 2013 Aug; 62(Pt 8): 1220–5.
Mayanskiy N, Savinova T, Alyabieva N, Ponomarenko O, Brzhozovskaya E, Lazareva A, et al.. Antimicrobial resistance, penicillin-binding protein sequences, and pilus islet carriage in relation to clonal evolution of Streptococcus pneumoniae serotype 19A in Russia, 2002–2013. Epidemiol Infect 2017; 145: 1708–19. Available from: https://doi.org/10.1017/S0950268817000541.
Zemlickova H, Jakubu V, Fridrichova M, Malisova L, Musilek M, Trojanek M. The association of pili with the emergence and replacement of the major antibiotic resistant pneumococcal clones. J Microbiol Immunol Infect 2020 Oct; 53(5): 690–695.